The progress of inflammation and oxidative stress in patients with chronic kidney disease

References

• Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: A cross-sectional survey. Lancet. 2012;379(9818):815–822
   PubMed Web of Science ®Google Scholar
• Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest. 2006;116(2):288–296
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Oveisi F, Ding Y. Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int. 1998;53(6):1748–1754
   PubMedGoogle Scholar
• Kotur-Stevuljevic J, Simic-Ogrizovic S, Dopsaj V, et al. A hazardous link between malnutrition, inflammation and oxidative stress in renal patients. Clin Biochem. 2012;45(15):1202–1205
   PubMedGoogle Scholar
• Massy ZA, Stenvinkel P, Drueke TB. The role of oxidative stress in chronic kidney disease. Semin Dial. 2009;22(4):405–408
   PubMedGoogle Scholar
• Keller CR, Odden MC, Fried LF, et al. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: The health, aging, and body composition study. Kidney Int. 2007;71(3):239–244
   PubMedGoogle Scholar
• Nerpin E, Helmersson-Karlqvist J, Risérus U, et al. Inflammation, oxidative stress, glomerular filtration rate, and albuminuria in elderly men: A cross-sectional study. BMC Res Notes. 2012;5:537
   PubMedGoogle Scholar
• Oberg BP, McMenamin E, Lucas FL, et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int. 2004;65(3):1009–1016
   PubMed Web of Science ®Google Scholar
• Morena M, Patrier L, Jaussent I, et al. Reduced glomerular filtration rate, inflammation and HDL cholesterol as main determinants of superoxide production in non-dialysis chronic kidney disease patients. Free Radic Res. 2011;45(6):735–745
   PubMed Web of Science ®Google Scholar
• Ward RA, McLeish KR. Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol. 1995;5(9):1697–1702
   PubMedGoogle Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–470
   PubMed Web of Science ®Google Scholar
• Bartnicki P, Fijałkowski P, Majczyk M, Błaszczyk J, Banach M, Rysz J. Effect of methoxy polyethylene glycol-epoetin beta on oxidative stress in predialysis patients with chronic kidney disease. Med Sci Monit. 2013;19:954–959
   PubMed Web of Science ®Google Scholar
• Liu ZH. Nephrology in China. Nat Rev Nephrol. 2013;9(9):523–528
   PubMed Web of Science ®Google Scholar
• Dounousi E, Papavasiliou E, Makedou A, et al. Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis. 2006;48(5):752–760
   PubMed Web of Science ®Google Scholar
• Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE, De Zeeuw D. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int. 2003;63(2):654661
   Google Scholar
• Pecoits-Filho R, Heimbürger O, Bárány P, et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis. 2003;41(6):1212–1218
   PubMed Web of Science ®Google Scholar
• Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. Serum malondialdehyde as biomarker for oxidative stress: Reference interval and effects of life-style factors. Clin Chem. 1997;43(7):1209–1214
   PubMed Web of Science ®Google Scholar
• Atamer A, Kocyigit Y, Ecder SA, et al. Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease. J Nephrol. 2008;21(6):924–930
   PubMedGoogle Scholar
• Wingler K, Wünsch S, Kreutz R, Rothermund L, Paul M, Schmidt HH. Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic Biol Med. 2001;31(11):1456–1464
   PubMedGoogle Scholar
• Miyata T, van Ypersele de Strihou C, Ueda Y, et al. Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: Biochemical mechanisms. J Am Soc Nephrol. 2002;13(10):2478–2487
   PubMed Web of Science ®Google Scholar
• Gupta S, Gambhir JK, Kalra O, et al. Association of biomarkers of inflammation and oxidative stress with the risk of chronic kidney disease in Type 2 diabetes mellitus in North Indian population. J Diabetes Complications. 2013;27(6):548–552
   PubMed Web of Science ®Google Scholar
• Kim CH, Vaziri ND. Hypertension promotes integrin expression and reactive oxygen species generation by circulating leukocytes. Kidney Int. 2005;67(4):1462–1470
   PubMedGoogle Scholar
• Manning RD Jr, Tian N, Meng S. Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol. 2005;25(4):311–317
   PubMed Web of Science ®Google Scholar
• Usharani P, Fatima N, Muralidhar N. Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: A randomized, double-blind, controlled study. Diabetes Metab Syndr Obes. 2013;6:275–284
   PubMedGoogle Scholar
• Lim CS, Vaziri ND. Iron and oxidative stress in renal insufficiency. Am J Nephrol. 2004;24(6):569–575
   PubMedGoogle Scholar
• Galli F, Ghibelli L, Buoncristiani U, et al. Mononuclear leukocyte apoptosis in haemodialysis patients: The role of cell thiols and vitamin E. Nephrol Dial Transplant. 2003;18(8):1592–600
   PubMedGoogle Scholar
• Stenvinkel P, Ketteler M, Johnson RJ, et al. IL-10, IL-6, and TNF-alpha: Central factors in the altered cytokine network of uremia—The good, the bad, and the ugly. Kidney Int. 2005;67(4):1216–1233
   PubMed Web of Science ®Google Scholar
• Sela S, Shurtz-Swirski R, Cohen-Mazor M, et al. Primed peripheral polymorphonuclear leukocyte: A culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol. 2005;16(8):2431–2438
   PubMed Web of Science ®Google Scholar
• Small DM, Coombes JS, Bennett N, Johnson DW, Gobe GC. Oxidative stress, anti-oxidant therapies and chronic kidney disease. Nephrology (Carlton). 2012;17(4):311–321
   PubMed Web of Science ®Google Scholar
• Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial. Lancet. 2000;356(9237):1213–1218
   PubMed Web of Science ®Google Scholar
• Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342(3):154–160
   PubMed Web of Science ®Google Scholar
• Xu G, Yan W, Li J. An update for the controversies and hypotheses of regulating nonthyroidal illness syndrome in chronic kidney diseases. Clin Exp Nephrol. 2014 Apr 22. [Epub ahead of print]. doi:10.1007/s10157-014-0974-1
   Google Scholar